case_images: PMC10928914_01
case_images: (A-C) Patient at baseline (D-F) Patient after 52-week of treatment with Guselkumab.
case_images: CCID-17-483-g0001.jpg
case_images: PMC10928914_01_CCID-17-483-g0001.jpg
case_images: f0001
case_images: HS since 3 years presenting nodules and fistulous routes in the axillary cavity, inguinal region, and on the buttocks (Hurley stage II, IHS4 16) (Figure 1A-C). The results were confirmed at week 52 (IHS4 5) (Figure 1D-F).